Skip to main content

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in KURA — Kura Oncology, Inc.

CIK 861177 NEW YORK, NY

Position in KURA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,345,414
+$336,053 QoQ
Shares Held
122,645
-1.2% QoQ
Ownership
0.138%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#72
of 220 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 46% Shared 0% None 54%

Common Shares in KURA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,443,898,601 across 206 Biotechnology names. KURA ranks #111 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KURA

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,345,414 122,645
2026-03-31 $1,009,361 124,153
2025-12-31 $1,110,573 106,889
2025-09-30 $980,277 110,766
2025-06-30 $1,094,683 189,720
2025-03-31 $1,004,068 152,132
2024-12-31 $1,147,261 131,718
2024-09-30 $2,396,931 122,668
2024-06-30 $2,575,888 125,104
2024-03-31 $1,848,582 86,666
2023-12-31 $1,177,086 81,856
2023-09-30 $746,525 81,856
2023-06-30 $422,871 39,969
2023-03-31 $488,818 39,969
2022-12-31 $569,853 45,919
2022-09-30 $627,252 45,919
2022-06-30 $6,240,664 340,462
2022-03-31 $5,636,535 350,531
2021-12-31 $5,204,500 371,750
2021-09-30 $7,176,114 383,135
2021-06-30 $8,187,019 392,663
2021-03-31 $8,480,320 299,976
2020-12-31 $8,469,258 259,316
2020-09-30 $1,185,767 38,700
2020-06-30 $623,311 38,240
2020-03-31 $154,383 15,516